Ayala Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
GORDON GARY B. officer: Chief Medical Officer
Common Stock 3,000 $5.16 $15,480
Option
GORDON GARY B. officer: Chief Medical Officer
Stock Option 3,000 $5.16 $15,480
Sale
GORDON GARY B. officer: Chief Medical Officer
Common Stock 3,000 $5.16 $15,480
Sale
MAMLUK RONI director, officer: President & ..
Common Stock 10,800 $17.4 $187,920
Sale
MAMLUK RONI director, officer: President & ..
Common Stock 7,126 N/A N/A
Sale
MAMLUK RONI director, officer: President & ..
Common Stock 15,200 N/A N/A
Sale
MAMLUK RONI director, officer: President & ..
Common Stock 1,406 N/A N/A
Option
GORDON GARY B. officer: Chief Medical Officer
Stock Option 3,000 N/A N/A
Sale
GORDON GARY B. officer: Chief Medical Officer
Common Stock 3,000 N/A N/A
Option
GORDON GARY B. officer: Chief Medical Officer
Common Stock 3,000 N/A N/A
Sale
MAMLUK RONI director, officer: President & ..
Common Stock 19,466 N/A N/A
Purchase
SIDRANSKY DAVID
Common Stock 4 N/A N/A
Purchase
SIDRANSKY DAVID
Common Stock 1 N/A N/A
Purchase
SIDRANSKY DAVID
Common Stock 10 N/A N/A
Purchase
SIDRANSKY DAVID
Common Stock 5 N/A N/A
Purchase
SIDRANSKY DAVID
Common Stock 4 N/A N/A
Purchase
SIDRANSKY DAVID
Common Stock 1 N/A N/A
Purchase
AMOON 2 FUND LIMITED PARTNERSHIP 10 percent owner
Common Stock 800,000 N/A N/A
Purchase
HAREL INSURANCE CO LTD 10 percent owner
Common Stock, par value $0.01 per share 550,000 N/A N/A
Purchase
ISRAEL BIOTECH FUND I, L.P. 10 percent owner
Common Stock 225,000 N/A N/A
Purchase
SIDRANSKY DAVID
Common Stock 25 N/A N/A
Purchase
SIDRANSKY DAVID
Common Stock 200 N/A N/A

Showing 1 to 22 of 22 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.